{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T23:30:44Z","timestamp":1793403044884,"version":"4.5.0"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T00:00:00Z","timestamp":1784592000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T00:00:00Z","timestamp":1784592000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Obes"],"published-print":{"date-parts":[[2026,10]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Erythritol is a non-nutritive sweetener that is also endogenously produced from glucose. We investigated whether declines in plasma erythritol and other sugar alcohols (polyols) in response to weight-loss dietary interventions were significantly associated with long-term improvements in glucose metabolism and insulin sensitivity.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      Plasma erythritol, mannitol\/sorbitol, and arabitol\/xylitol were repeatedly measured among adults with overweight or obesity who participated in the POUNDS Lost trial (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u2009802 at baseline and\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u2009664 at 6 months). We analyzed associations of changes in erythritol, mannitol\/sorbitol, and arabitol\/xylitol from baseline to 6 months with changes in homeostasis model assessment of insulin resistance (HOMA-IR), fasting insulin, fasting glucose, and HbA1c at 6 months and 2 years of intervention.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Plasma erythritol levels were positively related to HOMA-IR, fasting insulin, and glycemic markers at baseline. Greater declines in plasma erythritol in response to the interventions were associated with greater reductions in HOMA-IR (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.001) and fasting insulin (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.001) at 6 months. Similar associations were found for changes in arabitol\/xylitol, but not for mannitol\/sorbitol. Every 1\u2009SD reduction in plasma erythritol during the initial 6-month period was related to long-term (2-year) decreases in log-transformed HOMA-IR (\u03b2 [SE] \u20130.07 [0.02],\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.008) and glycemic markers (\u03b2 \u20131.0 [0.44] mg\/dL,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.025 for fasting glucose; \u03b2 \u20130.05% [0.02%],\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.019 for HbA1c).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Declines in plasma erythritol may be related to long-term improvements in insulin sensitivity and glycemic status during weight-loss dietary interventions in adults with overweight or obesity.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1038\/s41366-026-02152-w","type":"journal-article","created":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T00:44:56Z","timestamp":1784594696000},"page":"2157-2163","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Declines in plasma erythritol levels and improvements in insulin sensitivity and glucose metabolism: POUNDS lost trial"],"prefix":"10.1038","volume":"50","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0957-9309","authenticated-orcid":false,"given":"Yoriko","family":"Heianza","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5848-2987","authenticated-orcid":false,"given":"Jennifer C.","family":"Rood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine M.","family":"Champagne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank B.","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9945-8772","authenticated-orcid":false,"given":"George A.","family":"Bray","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank M.","family":"Sacks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8041-7791","authenticated-orcid":false,"given":"Lu","family":"Qi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,21]]},"reference":[{"key":"2152_CR1","doi-asserted-by":"publisher","first-page":"E4233","DOI":"10.1073\/pnas.1620079114","volume":"114","author":"KC Hootman","year":"2017","unstructured":"Hootman KC, Trezzi JP, Kraemer L, Burwell LS, Dong X, Guertin KA, et al. Erythritol is a pentose-phosphate pathway metabolite and associated with adiposity gain in young adults. Proc Natl Acad Sci USA. 2017;114:E4233\u2013e40.","journal-title":"Proc Natl Acad Sci USA"},{"key":"2152_CR2","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1093\/eurjpc\/zwae288","volume":"32","author":"Y Heianza","year":"2025","unstructured":"Heianza Y, Sun Q, Wang X, Tiwari S, Watrous JD, Rexrode KM, et al. Plasma levels of polyols erythritol, mannitol, and sorbitol and incident coronary heart disease among women. Eur J Prev Cardiol. 2025;32:404\u201314.","journal-title":"Eur J Prev Cardiol"},{"key":"2152_CR3","doi-asserted-by":"publisher","first-page":"1046","DOI":"10.1007\/s00125-018-4573-7","volume":"61","author":"CM Rebholz","year":"2018","unstructured":"Rebholz CM, Yu B, Zheng Z, Chang P, Tin A, K\u00f6ttgen A, et al. Serum metabolomic profile of incident diabetes. Diabetologia. 2018;61:1046\u201354.","journal-title":"Diabetologia"},{"key":"2152_CR4","doi-asserted-by":"publisher","first-page":"2136","DOI":"10.1161\/ATVBAHA.124.321019","volume":"44","author":"M Witkowski","year":"2024","unstructured":"Witkowski M, Wilcox J, Province V, Wang Z, Nemet I, Tang WHW, et al. Ingestion of the non-nutritive sweetener erythritol, but not glucose, enhances platelet reactivity and thrombosis potential in healthy volunteers-brief report. Arterioscler Thromb Vasc Biol. 2024;44:2136\u201341.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"2152_CR5","doi-asserted-by":"publisher","first-page":"2439","DOI":"10.1093\/eurheartj\/ehae244","volume":"45","author":"M Witkowski","year":"2024","unstructured":"Witkowski M, Nemet I, Li XS, Wilcox J, Ferrell M, Alamri H, et al. Xylitol is prothrombotic and associated with cardiovascular risk. Eur Heart J. 2024;45:2439\u201352.","journal-title":"Eur Heart J"},{"key":"2152_CR6","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1038\/s41591-023-02223-9","volume":"29","author":"M Witkowski","year":"2023","unstructured":"Witkowski M, Nemet I, Alamri H, Wilcox J, Gupta N, Nimer N, et al. The artificial sweetener erythritol and cardiovascular event risk. Nat Med. 2023;29:710\u20138.","journal-title":"Nat Med"},{"key":"2152_CR7","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacadv.2025.101605","volume":"4","author":"LA Abushamat","year":"2025","unstructured":"Abushamat LA, Yu B, Hoogeveen RC, Sun C, Cheng C, Hartig SM, et al. Erythritol, erythronate, and cardiovascular outcomes in older adults in the ARIC study. JACC Adv. 2025;4:101605.","journal-title":"JACC Adv"},{"key":"2152_CR8","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1080\/07388551.2020.1751057","volume":"40","author":"GA Mart\u0103u","year":"2020","unstructured":"Mart\u0103u GA, Coman V, Vodnar DC. Recent advances in the biotechnological production of erythritol and mannitol. Crit Rev Biotechnol. 2020;40:608\u201322.","journal-title":"Crit Rev Biotechnol"},{"key":"2152_CR9","doi-asserted-by":"crossref","unstructured":"Mazi TA, Stanhope KL. Erythritol: an in-depth discussion of its potential to be a beneficial dietary component. Nutrients 2023;15:204.","DOI":"10.3390\/nu15010204"},{"key":"2152_CR10","doi-asserted-by":"publisher","first-page":"16095","DOI":"10.1074\/jbc.RA119.009049","volume":"294","author":"L Schlicker","year":"2019","unstructured":"Schlicker L, Szebenyi DME, Ortiz SR, Heinz A, Hiller K, Field MS. Unexpected roles for ADH1 and SORD in catalyzing the final step of erythritol biosynthesis. J Biol Chem. 2019;294:16095\u2013108.","journal-title":"J Biol Chem"},{"key":"2152_CR11","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.1016\/S0278-6915(98)00091-X","volume":"36","author":"IC Munro","year":"1998","unstructured":"Munro IC, Berndt WO, Borzelleca JF, Flamm G, Lynch BS, Kennepohl E, et al. Erythritol: an interpretive summary of biochemical, metabolic, toxicological and clinical data. Food Chem Toxicol. 1998;36:1139\u201374.","journal-title":"Food Chem Toxicol"},{"key":"2152_CR12","doi-asserted-by":"publisher","first-page":"2114","DOI":"10.1093\/jn\/nxab130","volume":"151","author":"SR Ortiz","year":"2021","unstructured":"Ortiz SR, Field MS. Chronic dietary erythritol exposure elevates plasma erythritol concentration in mice but does not cause weight gain or modify glucose homeostasis. J Nutr. 2021;151:2114\u201324.","journal-title":"J Nutr"},{"key":"2152_CR13","doi-asserted-by":"publisher","first-page":"1889","DOI":"10.1016\/j.tjnut.2023.05.022","volume":"153","author":"SR Ortiz","year":"2023","unstructured":"Ortiz SR, Field MS. Sucrose intake elevates erythritol in plasma and urine in male mice. J Nutr. 2023;153:1889\u2013902.","journal-title":"J Nutr"},{"key":"2152_CR14","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.2337\/db15-0661","volume":"65","author":"L Chen","year":"2016","unstructured":"Chen L, Cheng CY, Choi H, Ikram MK, Sabanayagam C, Tan GS, et al. Plasma metabonomic profiling of diabetic retinopathy. Diabetes. 2016;65:1099\u2013108.","journal-title":"Diabetes"},{"key":"2152_CR15","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1136\/bmjnph-2023-000764","volume":"6","author":"V Bordier","year":"2023","unstructured":"Bordier V, Teysseire F, Drewe J, Mad\u00f6rin P, Bieri O, Schmidt-Trucks\u00e4ss A, et al. Effects of a 5-week intake of erythritol and xylitol on vascular function, abdominal fat and glucose tolerance in humans with obesity: a pilot trial. BMJ Nutr Prev Health. 2023;6:264\u201372.","journal-title":"BMJ Nutr Prev Health"},{"key":"2152_CR16","doi-asserted-by":"crossref","unstructured":"Bordier V, Teysseire F, Schlotterbeck G, Senner F, Beglinger C, Meyer-Gerspach AC, et al. Effect of a chronic intake of the natural sweeteners xylitol and erythritol on glucose absorption in humans with obesity. Nutrients. 2021;13:3950.","DOI":"10.3390\/nu13113950"},{"key":"2152_CR17","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1056\/NEJMoa0804748","volume":"360","author":"FM Sacks","year":"2009","unstructured":"Sacks FM, Bray GA, Carey VJ, Smith SR, Ryan DH, Anton SD, et al. Comparison of weight-loss diets with different compositions of fat, protein, and carbohydrates. N Engl J Med. 2009;360:859\u201373.","journal-title":"N Engl J Med"},{"key":"2152_CR18","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1007\/BF00280883","volume":"28","author":"DR Matthews","year":"1985","unstructured":"Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985;28:412\u20139.","journal-title":"Diabetologia"},{"key":"2152_CR19","doi-asserted-by":"publisher","first-page":"936","DOI":"10.1093\/ajcn\/36.5.936","volume":"36","author":"JA Baecke","year":"1982","unstructured":"Baecke JA, Burema J, Frijters JE. A short questionnaire for the measurement of habitual physical activity in epidemiological studies. Am J Clin Nutr. 1982;36:936\u201342.","journal-title":"Am J Clin Nutr"},{"key":"2152_CR20","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.ajcnut.2022.10.001","volume":"117","author":"Y Heianza","year":"2023","unstructured":"Heianza Y, Xue Q, Rood J, Bray GA, Sacks FM, Qi L. Circulating thrifty microRNA is related to insulin sensitivity, adiposity, and energy metabolism in adults with overweight and obesity: the POUNDS lost trial. Am J Clin Nutr. 2023;117:121\u20139.","journal-title":"Am J Clin Nutr"},{"key":"2152_CR21","doi-asserted-by":"publisher","first-page":"1737","DOI":"10.1056\/NEJMoa2102953","volume":"385","author":"LA Inker","year":"2021","unstructured":"Inker LA, Eneanya ND, Coresh J, Tighiouart H, Wang D, Sang Y, et al. New creatinine- and cystatin C-based equations to estimate GFR without race. N Engl J Med. 2021;385:1737\u201349.","journal-title":"N Engl J Med"},{"key":"2152_CR22","doi-asserted-by":"publisher","DOI":"10.1016\/j.metabol.2022.155312","volume":"136","author":"Y Heianza","year":"2022","unstructured":"Heianza Y, Wang X, Rood J, Clish CB, Bray GA, Sacks FM, et al. Changes in circulating bile acid subtypes in response to weight-loss diets are associated with improvements in glycemic status and insulin resistance: the POUNDS Lost trial. Metabolism. 2022;136:155312.","journal-title":"Metabolism"},{"key":"2152_CR23","first-page":"296","volume":"23","author":"SR Ortiz","year":"2020","unstructured":"Ortiz SR, Field MS. Mammalian metabolism of erythritol: a predictive biomarker of metabolic dysfunction. Curr Opin Clin Nutr Metab Care. 2020;23:296\u2013301.","journal-title":"Curr Opin Clin Nutr Metab Care"},{"key":"2152_CR24","doi-asserted-by":"publisher","first-page":"4270","DOI":"10.2337\/db13-0570","volume":"62","author":"C Menni","year":"2013","unstructured":"Menni C, Fauman E, Erte I, Perry JR, Kastenmuller G, Shin SY, et al. Biomarkers for type 2 diabetes and impaired fasting glucose using a nontargeted metabolomics approach. Diabetes. 2013;62:4270\u20136.","journal-title":"Diabetes"},{"key":"2152_CR25","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.metabol.2013.09.002","volume":"63","author":"K Mitsutomi","year":"2014","unstructured":"Mitsutomi K, Masaki T, Shimasaki T, Gotoh K, Chiba S, Kakuma T, et al. Effects of a nonnutritive sweetener on body adiposity and energy metabolism in mice with diet-induced obesity. Metabolism. 2014;63:69\u201378.","journal-title":"Metabolism"},{"key":"2152_CR26","doi-asserted-by":"crossref","unstructured":"Ahuja V, Macho M, Ewe D, Singh M, Saha S, Saurav K. Biological and pharmacological potential of xylitol: a molecular insight of unique metabolism. Foods. 2020;9:1592.","DOI":"10.3390\/foods9111592"},{"key":"2152_CR27","doi-asserted-by":"crossref","unstructured":"Salli K, Lehtinen MJ, Tiihonen K, Ouwehand AC. Xylitol\u2019s health benefits beyond dental health: a comprehensive review. Nutrients. 2019;11:1813.","DOI":"10.3390\/nu11081813"},{"key":"2152_CR28","doi-asserted-by":"publisher","first-page":"E1053","DOI":"10.1152\/ajpendo.00037.2016","volume":"310","author":"BK W\u00f6lnerhanssen","year":"2016","unstructured":"W\u00f6lnerhanssen BK, Cajacob L, Keller N, Doody A, Rehfeld JF, Drewe J, et al. Gut hormone secretion, gastric emptying, and glycemic responses to erythritol and xylitol in lean and obese subjects. Am J Physiol Endocrinol Metab. 2016;310:E1053\u201361.","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"2152_CR29","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1093\/ajcn\/65.4.947","volume":"65","author":"SS Natah","year":"1997","unstructured":"Natah SS, Hussien KR, Tuominen JA, Koivisto VA. Metabolic response to lactitol and xylitol in healthy men. Am J Clin Nutr. 1997;65:947\u201350.","journal-title":"Am J Clin Nutr"},{"key":"2152_CR30","doi-asserted-by":"crossref","unstructured":"Teysseire F, Bordier V, Beglinger C, W\u00f6lnerhanssen BK, Meyer-Gerspach AC. Metabolic effects of selected conventional and alternative sweeteners: a narrative review. Nutrients 2024;16:622.","DOI":"10.3390\/nu16050622"},{"key":"2152_CR31","doi-asserted-by":"publisher","first-page":"S31","DOI":"10.1093\/advances\/nmy037","volume":"10","author":"FJ Ruiz-Ojeda","year":"2019","unstructured":"Ruiz-Ojeda FJ, Plaza-Diaz J, Saez-Lara MJ, Gil A. Effects of sweeteners on the gut microbiota: a review of experimental studies and clinical trials. Adv Nutr. 2019;10:S31\u2013S48.","journal-title":"Adv Nutr"},{"key":"2152_CR32","doi-asserted-by":"publisher","first-page":"1311","DOI":"10.1111\/dom.14342","volume":"23","author":"BK W\u00f6lnerhanssen","year":"2021","unstructured":"W\u00f6lnerhanssen BK, Drewe J, Verbeure W, le Roux CW, Dellatorre-Teixeira L, Rehfeld JF, et al. Gastric emptying of solutions containing the natural sweetener erythritol and effects on gut hormone secretion in humans: A pilot dose-ranging study. Diabetes Obes Metab. 2021;23:1311\u201321.","journal-title":"Diabetes Obes Metab"},{"key":"2152_CR33","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajpc.2025.101325","volume":"24","author":"J Fan","year":"2025","unstructured":"Fan J, Hu Y, Zhang J, Chen J, Yuan Y, Yu B. Associations between artificial sweeteners and cardiovascular disease, stroke, and diabetes: a Mendelian randomization study. Am J Prev Cardiol. 2025;24:101325.","journal-title":"Am J Prev Cardiol"},{"key":"2152_CR34","doi-asserted-by":"publisher","first-page":"325","DOI":"10.2337\/db23-0330","volume":"73","author":"R Khafagy","year":"2024","unstructured":"Khafagy R, Paterson AD, Dash S. Erythritol as a potential causal contributor to cardiometabolic disease: a mendelian randomization study. Diabetes. 2024;73:325\u201331.","journal-title":"Diabetes"}],"container-title":["International Journal of Obesity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41366-026-02152-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41366-026-02152-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41366-026-02152-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T23:01:19Z","timestamp":1793401279000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41366-026-02152-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,21]]},"references-count":34,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["2152"],"URL":"https:\/\/doi.org\/10.1038\/s41366-026-02152-w","relation":{},"ISSN":["0307-0565","1476-5497"],"issn-type":[{"value":"0307-0565","type":"print"},{"value":"1476-5497","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,21]]},"assertion":[{"value":"28 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 May 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 June 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 July 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}]}}